Tuberculosis Treatment With a 3-Drug Rifamycin-Free Regimen in Liver Transplant Recipients.

Timothy F SullivanSamantha JacobsJennifer LeongDallas DunnEmily BanemanSarah TaimurShirish HuprikarMeenakshi Rana

Published in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2019)

Keyphrases

mycobacterium tuberculosis
adverse drug
emergency department
hiv aids
combination therapy
drug induced